Skip to main content

Cellular Dynamics Expands Distribution Deal in Japan

NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

The deal builds on a distribution agreement forged by the Madison, Wis.-based stem cell technology firm and the affiliate of Kyoto University in June 2011 covering iCardiomyocytes.

Robert Palay, CEO and chairman of CDI, said in a statement, "We view the expansion of our distribution agreement with iPS Academia Japan as a vote of confidence in our ability to provide human [induced pluripotent stem cell-derived] cells in the quantity, quality, and purity required for scientists to realize the full potential of their experiments."

iPS Academia Japan was originally created to manage the patents and technology based on the work of Shinya Yamanaka of Kyoto University, and CDI is the first foreign firm to be granted a license to Yamanaka's iPSC patent portfolio by iPS Academia Japan.

Financial and other terms were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.